Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-27 @ 10:59 PM
Study NCT ID:
NCT00378560
Status:
COMPLETED
Last Update Posted:
2017-04-17
First Post:
2006-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
V501 Efficacy Study in Women Aged 18 to 26 (V501-027)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Study Overview
Official Title:
V501 Phase II Efficacy Study in Women Aged 18 to 26
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A study to evaluate the efficacy, immunogenicity, safety and tolerability of V501 in adult women
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 2006_032 | None | None | View |